NCBI PubMed Central
open access
Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management.#170741
- Generation of human monoclonal autoantibodies from rare myelin oligodendrocyte glycoprotein-specific patient-derived B cells using an optofluidic-based platform#228125
- The Co-Production and Evaluation of the Computerised Cognitive Assessment for Preclinical Alzheimer's Disease (CoCoA-PAD)#858755
- Scrutinizing the Heterogeneity of SLE: Defining Phenotypes#897345
- γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma#858577
Record · ID 140481
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive